Literature DB >> 6749793

The development of 5-nitroimidazoles for the treatment and prophylaxis of anaerobic bacterial infections.

P Goldman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6749793     DOI: 10.1093/jac/10.suppl_a.23

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  13 in total

1.  Antibacterial activities of the antiparasitic drugs nifurtimox and benznidazole.

Authors:  H Hof
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

2.  Antibacterial activity of GO 10213, a nitroimidazole derivative.

Authors:  H Hof; J Ströder
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

3.  Interaction of metronidazole with DNA repair mutants of Escherichia coli.

Authors:  T C Yeung; B B Beaulieu; M A McLafferty; P Goldman
Journal:  Antimicrob Agents Chemother       Date:  1984-01       Impact factor: 5.191

Review 4.  Pharmacokinetics and pharmacodynamics of the nitroimidazole antimicrobials.

Authors:  K C Lamp; C D Freeman; N E Klutman; M K Lacy
Journal:  Clin Pharmacokinet       Date:  1999-05       Impact factor: 6.447

Review 5.  Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection.

Authors:  Patrizia Spigaglia
Journal:  Ther Adv Infect Dis       Date:  2016-02

6.  In vitro and in vivo activities of the nitroimidazole CGI 17341 against Mycobacterium tuberculosis.

Authors:  D R Ashtekar; R Costa-Perira; K Nagrajan; N Vishvanathan; A D Bhatt; W Rittel
Journal:  Antimicrob Agents Chemother       Date:  1993-02       Impact factor: 5.191

7.  Effect of different nitroheterocyclic compounds on aerobic, microaerophilic, and anaerobic bacteria.

Authors:  H Hof; J Ströder; J P Buisson; R Royer
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

Review 8.  Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy.

Authors:  A A Carmine; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-08       Impact factor: 9.546

9.  Ferredoxin-linked reduction of metronidazole in Clostridium pasteurianum.

Authors:  D L Lockerby; H R Rabin; L E Bryan; E J Laishley
Journal:  Antimicrob Agents Chemother       Date:  1984-11       Impact factor: 5.191

10.  Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.

Authors:  Eva Sapi; Navroop Kaur; Samuel Anyanwu; David F Luecke; Akshita Datar; Seema Patel; Michael Rossi; Raphael B Stricker
Journal:  Infect Drug Resist       Date:  2011-05-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.